Table of Content

Open Access iconOpen Access

CASE REPORT

Priapism as a possible acute side effect of radical radiotherapy for prostate cancer

Mark A. Lomaga1, Charles Hayter2

1 Medical Student, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
2 Department of Radiation Oncology, Toronto-Sunnybrook Cancer Centre, Toronto, Ontario, Canada
Address correspondence to Charles Hayter, MD, TorontoSunnybrook Cancer Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5 Canada

Canadian Journal of Urology 2004, 11(2), 2205-2206.

Abstract

We report a case of a 73 year-old male diagnosed with T1 N0 M0 prostate cancer, Gleason score 7, undergoing a course of radical radiotherapy using 7600 cGY delivered in 38 fractions. Several hours after receiving his 27th fraction, he reported experiencing a painful penile erection lasting more than 6 hours. A history and several investigations were conducted to determine the etiology of this adverse event. Although several possible etiologies were considered, the two most likely possibilities were direct prostate-irradiation and/or his use of alfuzosin, a novel alpha 1-adrenergic antagonist. A literature search revealed one case of priapism secondary to radiotherapy as well as reports of priapism associated with drugs similar to alfuzosin.

Keywords

priapism, radiotherapy, alfuzosin, alpha 1-adrenergic antagonist

Cite This Article

APA Style
Lomaga, M.A., Hayter, C. (2004). Priapism as a possible acute side effect of radical radiotherapy for prostate cancer. Canadian Journal of Urology, 11(2), 2205–2206.
Vancouver Style
Lomaga MA, Hayter C. Priapism as a possible acute side effect of radical radiotherapy for prostate cancer. Can J Urology. 2004;11(2):2205–2206.
IEEE Style
M.A. Lomaga and C. Hayter, “Priapism as a possible acute side effect of radical radiotherapy for prostate cancer,” Can. J. Urology, vol. 11, no. 2, pp. 2205–2206, 2004.



cc Copyright © 2004 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 34

    View

  • 23

    Download

  • 0

    Like

Share Link